ALLEGAN, Mich., Feb. 22 /PRNewswire-FirstCall/ -- The Perrigo Company
(Nasdaq: PRGO; TASE) today announced the appointment by the Board of
Directors of Ben-Zion Zilberfarb as a new director of the Company. Dr.
Zilberfarb was appointed to serve for a term expiring on the date of the
annual meeting in 2008.
Joseph C. Papa, Perrigo President and Chief Executive Officer, stated,
"Dr. Zilberfarb's outstanding background has served him well in leadership
roles on several boards. His broad business and economic acumen will allow
him to make excellent contributions to our Board. We are pleased to welcome
Ben-Zion to Perrigo."
Dr. Zilberfarb, 57, is a former Director General of Israel's Ministry
of Finance (1998 - 1999). He is a consultant and director for private and
public companies in the areas of banking, insurance, and private capital.
He is currently Professor of Economics at Bar-Ilan University and The
Edmond de Rothschild Professor of Global Asset Management at Netanya
Academic College. He is a Board member and Chairman of the Audit Committee
for Delek Group, a holding and management company investing in Israel and
abroad, and for the Israel Discount Bank, both of which are traded on the
Tel Aviv Stock Exchange. He is also a member of the Board and Audit
Committee for FundTech Ltd., which is a NASDAQ listed company that is a
leading provider of electronic payments, cash management and settlement
solutions for financial institutions.
The Perrigo Company is a leading global healthcare supplier and the
world's largest manufacturer of over-the-counter (OTC) pharmaceutical and
nutritional products for the store brand market. Store brand products are
sold by food, drug, mass merchandise, dollar store and club store retailers
under their own labels. The Company also develops, manufactures and markets
prescription generic drugs, active pharmaceutical ingredients and consumer
products, and operates manufacturing facilities in the United States,
Israel, the United Kingdom, Mexico, Germany and China. Visit Perrigo on the
Internet (http://www.perrigo.com).
Note: Certain statements in this press release are forward-looking
statements within the meaning of Section 21E of the Securities Exchange Act
of 1934, as amended, and are subject to the safe harbor created thereby.
These statements relate to future events or the Company's future financial
performance and involve known and unknown risks, uncertainties and other
factors that may cause the actual results, levels of activity, performance
or achievements of the Company or its industry to be materially different
from those expressed or implied by any forward-looking statements. In some
cases, forward-looking statements can be identified by terminology such as
"may," "will," "could," "would," "should," "expect," "plan," "anticipate,"
"intend," "believe," "estimate," "predict," "potential" or other comparable
terminology. Please see the "Cautionary Note Regarding Forward-Looking
Statements" on page 1 of the Company's Form 10-K for the year ended July 1,
2006, as well as the Company's subsequent filings with the Securities and
Exchange Commission, for a discussion of certain important factors that
relate to forward-looking statements contained in this press release.
Although the Company believes that the expectations reflected in these
forward-looking statements are reasonable, it can give no assurance that
such expectations will prove to be correct. Unless otherwise required by
applicable securities laws, the Company disclaims any intention or
obligation to update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise.
SOURCE Perrigo Company
 back to top
Related links:
http://www.perrigo.com/
CONTACT:
Arthur J. Shannon, Vice President, Investor
Relations and Communication, +1-269-686-1709, or
ajshannon@perrigo.com, or Ernest J. Schenk, Manager, Investor
Relations and Communication, +1-269-673-9212, or
eschenk@perrigo.com, both of Perrigo Company
|
